Related Experiment Video
Updated: May 11, 2026

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors
Published on: June 27, 2025
ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing
1School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
Abstract:
ZNF313 encoding a zinc-binding protein is located at chromosome 20q13.13, which exhibits a frequent genomic amplification in multiple human cancers. However, the biological function of ZNF313 remains largely undefined. Here we report that ZNF313 is an ubiquitin E3 ligase that has a critical role in the regulation of cell cycle progression, differentiation and senescence. In this study, ZNF313 is initially identified as a XIAP-associated factor 1 (XAF1)-interacting protein, which upregulates the stability and proapoptotic effect of XAF1. Intriguingly, we found that ZNF313 activates cell cycle progression and suppresses cellular senescence through the RING domain-mediated degradation of p21(WAF1). ZNF313 ubiquitinates p21(WAF1) and also destabilizes p27(KIP1) and p57(KIP2), three members of the CDK-interacting protein (CIP)/kinase inhibitor protein (KIP) family of cyclin-dependent kinase inhibitors, whereas it does not affect the stability of the inhibitor of CDK (INK4) family members, such as p16(INK4A) and p15(INK4B). ZNF313 expression is tightly controlled during the cell cycle and its elevation at the late G1 phase is crucial for the G1-to-S phase transition. ZNF313 is induced by mitogenic growth factors and its blockade profoundly delays cell cycle progression and accelerates p21(WAF1)-mediated senescence. Both replicative and stress-induced senescence are accompanied with ZNF313 reduction. ZNF313 is downregulated during cellular differentiation process in vitro and in vivo, while it is commonly upregulated in many types of cancer cells. ZNF313 shows both the nuclear and cytoplasmic localization in epithelial cells of normal tissues, but exhibits an intense cytoplasmic distribution in carcinoma cells of tumor tissues. Collectively, ZNF313 is a novel E3 ligase for p21(WAF1), whose alteration might be implicated in the pathogenesis of several human diseases, including cancers.
Insights
Zinc finger protein 313 (ZNF313) acts as an E3 ligase, degrading p21(WAF1) to promote cell cycle progression and suppress senescence. Its dysregulation is linked to human cancers.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Biology
Background:
- The function of ZNF313, a protein encoded by a gene located at chromosome 20q13.13 with frequent genomic amplification in cancers, is largely unknown.
- ZNF313 interacts with XIAP-associated factor 1 (XAF1), influencing XAF1 stability and proapoptotic activity.
Purpose of the Study:
- To elucidate the biological function of ZNF313.
- To investigate the role of ZNF313 in cell cycle regulation, differentiation, and senescence.
- To determine the mechanism by which ZNF313 affects cell cycle inhibitors.
Main Methods:
- Protein-protein interaction studies to identify ZNF313 interactors.
- Ubiquitination assays to assess ZNF313's ligase activity.
- Cell cycle analysis and senescence assays.
- Western blotting to evaluate protein stability.
Main Results:
- ZNF313 functions as an E3 ubiquitin ligase, specifically targeting p21(WAF1) for degradation via its RING domain, thereby activating cell cycle progression and inhibiting senescence.
- ZNF313 destabilizes other cyclin-dependent kinase inhibitors (CKIs) including p27(KIP1) and p57(KIP2), but not the INK4 family members.
- ZNF313 expression is cell cycle-regulated, peaking in late G1, and is induced by growth factors; its reduction is associated with senescence and differentiation, while its upregulation is common in cancer cells.
Conclusions:
- ZNF313 is a novel E3 ligase that degrades p21(WAF1) and other CIP/KIP family members, playing a critical role in cell cycle control and senescence.
- The alteration of ZNF313 expression and localization is implicated in the pathogenesis of human diseases, particularly cancers.
- ZNF313's function as a regulator of cell cycle progression and senescence suggests its potential as a therapeutic target in cancer.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

